ARTICLE | Clinical News
MolecularBreeding molecular evolution technology regulatory update
August 28, 2000 7:00 AM UTC
MAXY received U.S. Patent No. 6,096,548 covering the use of its directed evolution technology to develop viral vectors with enhanced ability to target specific cells. The company said targeted viruses...